Jane Street’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $748K | Buy |
+84,519
| New | +$748K | ﹤0.01% | 3217 |
|
2025
Q1 | – | Sell |
-100,118
| Closed | -$1.05M | – | 5587 |
|
2024
Q4 | $1.05M | Buy |
100,118
+1,561
| +2% | +$16.4K | ﹤0.01% | 2882 |
|
2024
Q3 | $1.29M | Buy |
98,557
+30,039
| +44% | +$394K | ﹤0.01% | 3022 |
|
2024
Q2 | $963K | Buy |
68,518
+11,913
| +21% | +$167K | ﹤0.01% | 3723 |
|
2024
Q1 | $956K | Sell |
56,605
-53,300
| -48% | -$900K | ﹤0.01% | 3271 |
|
2023
Q4 | $1.55M | Buy |
109,905
+88,225
| +407% | +$1.25M | ﹤0.01% | 2799 |
|
2023
Q3 | $223K | Sell |
21,680
-236,370
| -92% | -$2.43M | ﹤0.01% | 4325 |
|
2023
Q2 | $4.25M | Buy |
258,050
+232,151
| +896% | +$3.83M | ﹤0.01% | 1643 |
|
2023
Q1 | $237K | Sell |
25,899
-49,000
| -65% | -$449K | ﹤0.01% | 4509 |
|
2022
Q4 | $536K | Buy |
+74,899
| New | +$536K | ﹤0.01% | 3307 |
|
2022
Q3 | – | Sell |
-33,220
| Closed | -$81K | – | 5732 |
|
2022
Q2 | $81K | Buy |
33,220
+4,816
| +17% | +$11.7K | ﹤0.01% | 4812 |
|
2022
Q1 | $194K | Sell |
28,404
-52,265
| -65% | -$357K | ﹤0.01% | 4727 |
|
2021
Q4 | $652K | Buy |
+80,669
| New | +$652K | ﹤0.01% | 3188 |
|
2021
Q3 | – | Sell |
-17,397
| Closed | -$117K | – | 5176 |
|
2021
Q2 | $117K | Sell |
17,397
-61,808
| -78% | -$416K | ﹤0.01% | 4698 |
|
2021
Q1 | $716K | Buy |
79,205
+61,660
| +351% | +$557K | ﹤0.01% | 2924 |
|
2020
Q4 | $117K | Buy |
+17,545
| New | +$117K | ﹤0.01% | 3607 |
|
2020
Q3 | – | Hold |
0
| – | – | – | 3745 |
|
2020
Q2 | – | Hold |
0
| – | – | – | 3947 |
|
2019
Q4 | – | Sell |
-13,819
| Closed | -$57K | – | 3255 |
|
2019
Q3 | $57K | Buy |
+13,819
| New | +$57K | ﹤0.01% | 3238 |
|
2014
Q3 | – | Sell |
-18,523
| Closed | -$278K | – | 2177 |
|
2014
Q2 | $278K | Buy |
+18,523
| New | +$278K | ﹤0.01% | 1645 |
|